Anticoagulants and reversal

Slides:



Advertisements
Similar presentations
Basic coagulation techniques and Quality control issues
Advertisements

Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
Educational Event 23rd & 24th January 2013
J. Bormanis/ cg edits  When did it start ?  Dental history  Spontanous bruising  Bleeding at surgery  Bleeding into joints  Menstrual bleeding.
Reversal of TSOACs 1 st Qatar Conference on Safe Anticoagulation Management (QCSAM): New Advances and Trends 28 February 2015 Scott Kaatz, DO, MSc, FACP,
What a Bloody Mess! A/Professor Kent Robinson Senior Staff Specialist, Liverpool & Campbelltown Hospitals.
Brad Beckham T4. Definitions  Major blood loss Hemoglobin concentration below 6-10 g/dl  Massive transfusion in adults >9 erythrocyte units within 24h.
New Oral Anticoagulants (NOACs) Dabigatran and Rivaroxaban for the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation Dr Dipti.
Haematology. Help I need blood! Both O negative and group specific are unsuitable for patients with antibodies…
Question: How should we manage periprocedural anticoagulation? Paper: Management of Antithrombotic Therapy in Patients Undergoing Invasive Procedures Todd.
Faculty of Allied Medical Science
The GARFIELD Registry is funded by an unrestricted research grant from Bayer Pharma AG Alexander G G Turpie Professor Emeritus of.
CLINICAL CASES.
NEW ORAL ANTICOAGULANTS
Octaplex – The Modern PCC
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Inherited Bleeding Disorders Factor X Deficiency Galila Zaher, MRCPath Assistant Professor Consultant Hematologist KAUH.
Dalia Elfawy., MD Lecturer of Anesthesia and ICU Ain Shams University 2014 RAPID REVERSAL OF ANTICOAGULATION IN TRAUMA PATIENTS.
Journal Club – September Coagulation – Brief Review.
Andres Ferber MD September
Care of the Anti-coagulated Trauma Patient Julie Mayglothling, MD, FACEP Emergencies in Medicine March 8 th, 2012.
Anticoagulants 1. Parenteral Anticoagulants e.g. heparin
Emergency anticoagulant reversal B Vigué, DAR, CHU Bicêtre.
Adam M. Levine, DO, FACC Clinical Assistant Professor of Medicine Rowan University September 12 th, 2015.
FERNE/EMRA How do we treat ICH patients with an elevated INR Andy Jagoda, MD, FACEP Professor and Vice Chair Department of Emergency Medicine Mount Sinai.
Role of Factor Concentrates in Perioperative Coagulopathies Dr Neville Gibbs Department of Anaesthesia Sir Charles Gairdner Hospital.
 Background  Cost  Benefit  Complication.
PRE-OPERATIVE PRE - MEDICATION. Pre-medication  Pre-medication is the administration of drugs before anesthesia.  Pre-medication is used to prepare.
1 Ultra-rapid management of oral anticoagulant therapy- related surgical intracranial hemorrhage Intensive Care Medicine (2007) 33: Zohra Daw, MD,
General principles for preventing high INR Simple dental or dermatological procedures may not require interruption to warfarin therapy. Simple dental.
Factor Eight Inhibitor Bypassing Activity (FEIBA) for the Rapid Reversal of Major Bleeding in Patients with Warfarin Induced Coagulopathy: A Pilot Study.
Fred V. Plapp MD PhD Pathology and Laboratory Medicine
Anticoagulation in Atrial Fibrillation Dalia Hawwass PGY2 June 2015.
University of North Carolina-Chapel Hill Division of Hematology
April 23, 2015 Mini-Lecture Nathan King M.D. Anticoagulation Reversal Part 1: Warfarin.
Systemic anticoagulation during ECMO is intended to control thrombin generation and limit the risk for thrombotic and hemorrhagic complications.
BLOOD COMPONENTS AND BLOOD DERIVATIVES
Timeline of Anticoagulation Options
Prothrombin Complex Concentrate- Octaplex
Prothrombin complex concentrate
AUB:Iatrogent Coagulopathy
Rapid Reversal of Warfarin Therapy in Patients with Intracranial / Intraspinal Bleeding Mount Auburn Hospital Blood Bank, Emergency Department, Critical.
You can never be too Thin…. An Update on NOACs
Warfarin Toxicity Treatment & Management
Anticoagulants in the Treatment of Venous Thromboembolism
Anticoagulation in chronic liver disease
Anticoagulation in Atrial Fibrillation
University of North Carolina-Chapel Hill Division of Hematology
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
In the name of God. Management trauma in elderly DR. NIKSOLAT GERIATRICIAN ASSISTANT PROFESSOR, IRAN UNIVERSITY OF MEDICAL SCIENCE.
Anticoagulation Prepared by Cherie Gan.
Oral Anticoagulants and Reversal Agents
Managing Bleeds in Patients Anticoagulated With Warfarin and Other Agents.
Suggested approach to patients with dabigatran-associated bleeding
Reversal of Direct Oral Anticoagulants (DOAC)
Reversal Strategies for VKA: Truths and Misconceptions
New oral anticoagulants—what the cardiothoracic surgeon needs to know
Direct Oral Anticoagulants
Evidence Supporting Idarucizumab for the Reversal of Dabigatran
Oral Anticoagulant Reversal Agents
Anticoagulant Reversal
Periprocedural Management of Patients on Anticoagulation
A Real Headache: Anticoagulation and a Subdural Hematoma
Ex vivo reversal of effects of rivaroxaban evaluated using thromboelastometry and thrombin generation assay  B. Schenk, P. Würtinger, W. Streif, W. Sturm,
A. Kisilevsky, A.W. Gelb, M. Bustillo, A.M. Flexman 
Journal club govaresh Dr ali gavidel Dr sadr azar.
Arman Qamar et al. JACC 2018;71:
RE-ALIGN Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement.
Drug Summary Info Document Request / monitor Goal of therapy Action
Use Fixed low dose Prothrombin Complex Concentrate (Octaplex)
Presentation transcript:

Anticoagulants and reversal

Warfarin Reversal There are guidelines. Look them up each time INR <4.5 without bleed Reduce or omit next dose INR 4.5-10 without bleed Withold warfarin 1-2mg vit K orally Repeat INR in 24-48 hours INR >10 without bleed Vit K 3-5mg oral/IV Consider PCC if high risk Repeat INR 12-24 hours

Bleeding Major bleed, INR >1.5 Significant bleed and INR >2 Intracranial, spinal, life threatening PCC 50iu/kg 150-300mL FFP (15mL/kg if PCC unavailable) Vit K 5-10mg IV Significant bleed and INR >2 PCC 35-50iu/KG dependent on INR Minor bleed 1 unit FFP Vit K 1-2mg orally or 0.51mg IV if INR >4.5 or bleeding risk high

Vitamin K Slow – several hours to take effect Don’t give more than you need – makes restarting warfarin very difficult Don’t give IM

Fresh frozen plasma Acute reversal in active bleeding Dose is 1 unit if PCC used, 4 units if not (to start) Has native INR 1.5 Does not fully replace factor IX Has factor VII which Prothrombinex does not Slow to get Large volume

Prothrombin complex concentrate Freeze dried factors II, IX, X Very small amount of factor VII PCC and FFP together will reverse warfarin in ~15 minutes Target INR Current INR Dose (IUnits/kg) Normalisation 1.5 - 2.5 30   2.6 - 3.5 35 ≥ 3.6 50 1.4 - 2.0 15 25 3.6 - 10 >10 40 Dose calculator

Dabigatran Direct thrombin inhibitor Behaves like a drug T ½ 14-17 hours, longer in renal failure APTT best for measurement – OK if normal Reversal – ?? PCC does not seem to work aPCC (FEIBA) might be better – but we don’t have any Can be dialysed

Rivaroxaban/Apixaban Factor X antagonist Also like a drug T1/2 7-14 hours – more with rivaroxaban in renal failure. APTT and PT prolonged Reversal with PCC – 50iu/kg, weak evidence. Protein bound, cannot be dialysed

NOACS and Coags Parameter Apixaban Dabigatran Rivaroxaban PT Prolonged No effect APTT Prolonged (1.4-1.8 times normal for therapeutic levels) Prolonged (1.5-1.8 times control) Thrombin time INR Not useful